Matinas BioPharma Holdings Inc
AMEX:MTNB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Ravi Kumar Distilleries Ltd
NSE:RKDL
|
IN |
|
Brother Enterprises Holding Co Ltd
SZSE:002562
|
CN |
|
Warehouses de Pauw NV
XBRU:WDP
|
BE |
|
A
|
Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153
|
CN |
|
Newcapec Electronics Co Ltd
SZSE:300248
|
CN |
|
I
|
Inmobiliaria San Patricio SA
SGO:ISANPA
|
CL |
|
Zhejiang Sunoren Solar Technology Co Ltd
SSE:603105
|
CN |
|
G
|
Greentown Management Holdings Company Ltd
HKEX:9979
|
CN |
|
M
|
Morris Home Holdings Ltd
HKEX:1575
|
CN |
|
Brenntag SE
XETRA:BNR
|
DE |
During the last 3 months Matinas BioPharma Holdings Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 7% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/amex/mtnb/vs/indx/gspc">open performance analysis).
The last transaction was made on Apr 8, 2025 by Sanitam Partners Llc , who bought 703k USD worth of MTNB shares.
During the last 3 months Matinas BioPharma Holdings Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 7% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/amex/mtnb/vs/indx/gspc">open performance analysis).
The last transaction was made on Apr 8, 2025 by Sanitam Partners Llc , who bought 703k USD worth of MTNB shares.
Matinas BioPharma Holdings Inc
Glance View
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Bedminster, New Jersey and currently employs 34 full-time employees. The company went IPO on 2014-06-03. The firm is focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology (LNC Platform) to maximize global clinical impact and patient access. The Company’s lead anti-fungal product candidate, MAT2203, is an application of its LNC Platform to a broad spectrum and potent anti-fungal drug called amphotericin B. Its second clinical-stage LNC-based product candidate is MAT2501, an orally administered formulation of the broad-spectrum aminoglycoside antibiotic amikacin, which may be used to treat different types of multidrug-resistant bacteria, including NTM, as well as various multidrug-resistant gram-negative and intracellular bacterial infections. The company also has internal discovery programs ongoing in the formulation and delivery of small oligonucleotides, namely antisense oligonucleotides (ASOs) and silencing or short interfering RNAs (siRNAs).
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.